Y. Wang

发表

RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene

C. Xuan, Q. Wang, X. Han, 2013, Oncogene.

mTORC1 enhancement of STIM1-mediated store-operated Ca2+ entry constrains tuberous sclerosis complex-related tumor development

Y. Wang, J. Li, Y. Jing, 2013, Oncogene.

Notch3 is important for TGF-β-induced epithelial–mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1

Liwen Liu, Y. Wang, Xiaolong Yan, 2014, Cancer Gene Therapy.

Regulation of the cell cycle machinery by oncogenic ras.

Y. Wang, J. Winston, S. R. Coats, 1996, Oncogene.

A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells

Y. Wang, J. Kreisberg, P. Ghosh, 2007, Oncogene.

Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival

Y. Wang, P. Ghosh, M. Mikhailova, 2008, Oncogene.

Partially transformed T3T3 cells express high levels of mutant p53 in the 'wild-type' immunoreactive form with defective oligomerization.

J. Milner, E. Medcalf, Y. Wang, 1993, Oncogene.

MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability

Y. Wang, C. Wan, R. Ni, 2013, Oncogene.

KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2

L. Jia, Y. Wang, H. Zhang, 2016, Oncogene.

Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion

Y. Wang, H. Ng, K. Li, 2010, Oncogene.

Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade

E. Lengyel, Y. Wang, D. Boyd, 1997, Oncogene.

GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation

X. Li, L. Liu, C. Xuan, 2014, Oncogene.

Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines

R. Deng, Y. Wang, Y-X Zeng, 2006, Oncogene.

Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules

H. Allgayer, A. Mazar, Y. Wang, 1998, Oncogene.

Cyclin D3 action in androgen receptor regulation and prostate cancer

J. Meller, Y. Wang, K. Knudsen, 2008, Oncogene.

Lipocalin 2 is required for BCR-ABL-induced tumorigenesis

Alan Aderem, J. Belmont, A. Aderem, 2008, Oncogene.

Acetylcholinesterase expression mediated by c-Jun-NH2-terminal kinase pathway during anticancer drug-induced apoptosis

Y. Wang, Y-X Zeng, Y. Mei, 2006, Oncogene.

Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms

J. Pfeifer, M. Pan, Y. Wang, 2014, Oncogene.

Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors

Y. Wang, H. Zhang, J. Zhao, 2014, Gene Therapy.

Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth

L. Ye, X. Zhang, W. Zhang, 2016, Oncogene.

KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition

Qing-Yu He, Y. Wang, W. Xu, 2017, Oncogene.

Blood vessel endothelium-directed tumor cell streaming in breast tumors requires the HGF/C-Met signaling pathway

J. Condeelis, R. Eddy, Y. Wang, 2016, Oncogene.

PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells

Jian Yu, J. Grandis, Z. Chen, 2009, Oncogene.

Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo

W. Grady, Y. Wang, S. Morris, 2014, Oncogene.

Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter

C. Moskaluk, H. Frierson, G. Hampton, 2016, Oncogene.

Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC

O. Pertz, J. Copeland, Y. Wang, 2010, Oncogene.

A novel Ku70 function in colorectal homeostasis separate from nonhomologous end joining

S. Li, O. Tavana, Y. Wang, 2014, Oncogene.

CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations

D. Elder, K. Flaherty, M. Herlyn, 2009, Oncogene.

The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells

R. Deng, Lei Wang, Y. Wang, 2009, Oncogene.

Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells

L. Staudt, J. Downward, Y. Wang, 2010, Oncogene.

CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma

Y. Zhai, S. Li, N. Zeps, 2017, Oncogene.

Twist1/Dnmt3a and miR186 establish a regulatory circuit that controls inflammation-associated prostate cancer progression

Y. Wang, R. Deng, J. Yu, 2017, Oncogenesis.

CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing

Y. Shang, Y. Wang, R. Qiu, 2013, Oncogene.

Clinical activity of MAPK targeted therapies in patients with non-V600 BRAF mutant tumors

D. Cescon, M. Gerlinger, J. Sosman, 2022, medRxiv.

LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump

G. Yao, Y. Wang, J. Gu, 2013, Oncogene.

MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells

Y. Wang, Y. Xu, J. Zhao, 2017, Oncogene.

CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer

W. Jiang, Z. Cai, X. Zhang, 2013, Oncogene.

SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma

B. Mao, W. Bi, Y. Wang, 2014, Oncogene.

Laser microdissection and microarray analysis of breast tumors reveal ER-α related genes and pathways

J. Foekens, A. Sieuwerts, M. Timmermans, 2006, Oncogene.

Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers

R. Silverman, C. Eng, M. Tan, 2011, Oncogene.

Pivotal role of augmented αB-crystallin in tumor development induced by deficient TSC1/2 complex

D. Kwiatkowski, Y. Wang, H. Peng, 2014, Oncogene.

The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair

A. Bergman, W. Edelmann, W. Zhang, 2014, Oncogene.

Genome-wide functional screening identifies CDC37 as a crucial HSP90-cofactor for KIT oncogenic expression in gastrointestinal stromal tumors

D. Root, J. Fletcher, G. Demetri, 2014, Oncogene.

A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk

H. Jiang, X. Li, Y. Wang, 2015, Oncogene.

The HIF/PHF8/AR axis promotes prostate cancer progression

Y. Wang, W. Yuan, S. Dong, 2016, Oncogenesis.

Inhibition of MAPK pathway is essential for suppressing Rheb-Y35N driven tumor growth

Guowang Xu, D. Kwiatkowski, G. Li, 2017, Oncogene.

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects

Y. Wang, R. Arlinghaus, T. Sun, 2008, Oncogene.

MicroRNA-21 promotes proliferation of rat hepatocyte BRL-3A by targeting FASLG.

Y. Wang, C. Xu, W. Y. Leung, 2015, Genetics and molecular research : GMR.